应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
MRK 默沙东
交易中 11-21 15:56:42 EST
100.15
+2.71
+2.78%
最高
100.48
最低
96.95
成交量
1,107万
今开
97.66
昨收
97.44
日振幅
3.62%
总市值
2,533亿
流通市值
2,529亿
总股本
25.30亿
成交额
10.94亿
换手率
0.44%
流通股本
25.25亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
默沙东涨2.63% 股价突破100美元大关
市场透视 · 02:33
默沙东涨2.63% 股价突破100美元大关
默沙东上涨1.24%,报98.651美元/股
金融界 · 00:44
默沙东上涨1.24%,报98.651美元/股
默沙东(MRK.US)HIF-2α抑制剂在华获批上市
智通财经 · 11-21 21:12
默沙东(MRK.US)HIF-2α抑制剂在华获批上市
港股异动 | 和誉-B(02256)再涨近4% 匹米替尼III期临床结果公布 默克有较大可能行使全球商业化选择权
智通财经 · 11-21 14:43
港股异动 | 和誉-B(02256)再涨近4% 匹米替尼III期临床结果公布 默克有较大可能行使全球商业化选择权
牵手默沙东、获中生制药入股!礼新医药成创新药黑马,管线BD交易总额已超280亿
时代周报 · 11-21 07:33
牵手默沙东、获中生制药入股!礼新医药成创新药黑马,管线BD交易总额已超280亿
默沙东上涨1.31%,报97.8美元/股
金融界 · 11-20 22:54
默沙东上涨1.31%,报97.8美元/股
媒体-随着本土竞争加剧,J&J和默克在华裁员 - 彭博新闻社
Reuters · 11-20 16:28
媒体-随着本土竞争加剧,J&J和默克在华裁员 - 彭博新闻社
港股异动 | 和誉-B(02256)现涨超4% 匹米替尼III期临床试验结果公布 默克若选择行权将增厚公司业绩
智通财经 · 11-20 13:49
港股异动 | 和誉-B(02256)现涨超4% 匹米替尼III期临床试验结果公布 默克若选择行权将增厚公司业绩
牵手默沙东、阿斯利康、中生制药,礼新医药两年卖出280亿
新康界 · 11-20 13:23
牵手默沙东、阿斯利康、中生制药,礼新医药两年卖出280亿
专利悬崖危机解除?默沙东(MRK.US)Keytruda皮下注射版本达到3期试验主要终点
智通财经网 · 11-20 11:50
专利悬崖危机解除?默沙东(MRK.US)Keytruda皮下注射版本达到3期试验主要终点
默沙东中国市场挑战加剧:业绩缩水,裁员计划开启
21世纪经济报道 · 11-20 11:07
默沙东中国市场挑战加剧:业绩缩水,裁员计划开启
BUZZ-默克公司在发现注射用 Keytruda 与已获批准的静脉注射型相同后股价上涨
路透中文 · 11-19 22:08
BUZZ-默克公司在发现注射用 Keytruda 与已获批准的静脉注射型相同后股价上涨
又一家跨国药企在华人员优化 这次是默沙东中国糖尿病业务
第一财经 · 11-19 20:23
又一家跨国药企在华人员优化 这次是默沙东中国糖尿病业务
国产分子在海外成为王炸
瞪羚社 · 11-19 20:04
国产分子在海外成为王炸
默克公司称Keytruda注射液在试验中与已获批的静脉注射版效果相当
Reuters · 11-19 19:46
默克公司称Keytruda注射液在试验中与已获批的静脉注射版效果相当
一周内官宣4笔BD交易!双抗新药赛道火爆,跨国药企砸百亿在华“扫货”
时代财经 · 11-19 14:17
一周内官宣4笔BD交易!双抗新药赛道火爆,跨国药企砸百亿在华“扫货”
默沙东:质疑Summit,成为Summit
新康界 · 11-18
默沙东:质疑Summit,成为Summit
“新冠富豪”再加码,默沙东态度大转变,下一个大药机会来临
CPHI制药在线 · 11-17
“新冠富豪”再加码,默沙东态度大转变,下一个大药机会来临
近33亿美元!默沙东“牵手”礼新医药,PD-(L)1/VEGF领域交易频发
21世纪经济报道 · 11-16
近33亿美元!默沙东“牵手”礼新医药,PD-(L)1/VEGF领域交易频发
多种模式并驾齐驱 创新药出海捷报频传
美港电讯 · 11-16
多种模式并驾齐驱 创新药出海捷报频传
加载更多
公司概况
公司名称:
默沙东
所属市场:
NYSE
上市日期:
--
主营业务:
默克制药公司于1970年在新泽西州注册成立。该公司是一家全球医疗保健公司,通过其处方药提供创新的健康解决方案,包括生物疗法、疫苗和动物保健产品。该公司的营运主要以产品为基础进行管理,包括两个经营分部:制药及动物保健国际。
发行价格:
--
{"stockData":{"symbol":"MRK","market":"US","secType":"STK","nameCN":"默沙东","latestPrice":100.15,"timestamp":1732222601776,"preClose":97.44,"halted":0,"volume":11068453,"delay":0,"floatShares":2525118727,"shares":2529635645,"eps":4.779697,"marketStatus":"交易中","marketStatusCode":2,"change":2.71,"latestTime":"11-21 15:56:42 EST","open":97.655,"high":100.48,"low":96.95,"amount":1093597136.55071,"amplitude":0.036227,"askPrice":100.16,"askSize":100,"bidPrice":100.14,"bidSize":262,"shortable":3,"etf":0,"ttmEps":4.779697,"exchange":"NYSE","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1732222800000},"adr":0,"listingDate":-745790400000,"adjPreClose":97.44,"adrRate":0,"dividendRate":0.030354,"preHourTrading":{"tag":"盘前","latestPrice":97.68,"preClose":97.44,"latestTime":"09:29 EST","volume":23227,"amount":2263807.4769599997,"timestamp":1732199391073},"postHourTrading":{"tag":"盘后","latestPrice":97.42,"preClose":97.44,"latestTime":"19:59 EST","volume":3059457,"amount":298113472.651,"timestamp":1732150789166},"volumeRatio":0.864146,"impliedVol":0.2473,"impliedVolPercentile":0.7381},"requestUrl":"/m/hq/s/MRK","defaultTab":"news","newsList":[{"id":"2485344611","title":"默沙东涨2.63% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2485344611","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485344611?lang=zh_cn&edition=full","pubTime":"2024-11-22 02:33","pubTimestamp":1732214023,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日02时33分,默沙东股票出现波动,股价急速拉升2.63%。截至发稿,该股报100.00美元/股,成交量669.864万股,换手率0.26%,振幅3.15%。默沙东股票所在的制药行业中,整体跌幅为0.24%。此外,默沙东还销售与动物健康相关的药物。继强生公司启动新一轮的裁员调整之后,另一家知名的跨国制药企业默沙东也在中国市场宣布了裁员计划。第一季度,裁员人数接近3000人,第二季度全球医药器械企业报告的裁员次数超过45次。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112202334498e43fcf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112202334498e43fcf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1066051811.HKD","LU1941712348.USD","IE00BSNM7G36.USD","LU0203345920.USD","LU0265550359.USD","LU2112291526.USD","IE00BFTCPJ56.SGD","BK4534","LU0965509010.AUD","LU0861579265.USD","LU1093756168.USD","LU0122379950.USD","LU1585245621.USD","LU2361044865.SGD","LU0965509101.SGD","LU2461242641.AUD","SG9999014567.USD","LU0058720904.USD","IE00BLSP4452.SGD","IE00BJT1NW94.SGD","LU0320765489.SGD","SG9999001176.USD","SGXZ57979304.SGD","SG9999014575.USD","IE0002141913.USD","LU0985320562.USD","LU2324357040.USD","BK4533","MRK","BK4516","IE00B1BXHZ80.USD","BK4588","BK4559","LU1291159041.SGD","LU2023250504.SGD","SG9999014559.SGD","LU1057294990.SGD","LU2361044949.HKD","LU1974910355.USD","IE00BJJMRZ35.SGD","LU1066051498.USD","LU1934455277.USD","SG9999013999.USD","LU1037948897.HKD","LU0265550946.USD","BK4007","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU0238689110.USD","IE000M9KFDE8.USD"],"gpt_icon":0},{"id":"2485412862","title":"默沙东上涨1.24%,报98.651美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2485412862","media":"金融界","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485412862?lang=zh_cn&edition=full","pubTime":"2024-11-22 00:44","pubTimestamp":1732207468,"startTime":"0","endTime":"0","summary":"11月22日,默沙东(MRK)盘中上涨1.24%,截至00:44,报98.651美元/股,成交3.71亿美元。财务数据显示,截至2024年09月30日,默沙东收入总额485.44亿美元,同比增长6.73%;归母净利润133.74亿美元,同比增长740.6%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/11/22004445553277.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU1116320901.HKD","LU1093756168.USD","LU0265550946.USD","BK4516","LU0965509010.AUD","LU2023250504.SGD","LU0265550359.USD","LU1061106388.HKD","LU0106261372.USD","LU0965509283.SGD","IE00B1BXHZ80.USD","SG9999014559.SGD","IE00BBT3K403.USD","LU1023059063.AUD","IE00BN8TJ469.HKD","LU0234572021.USD","LU1066051498.USD","LU0070302665.USD","SG9999001176.SGD","LU2361045086.USD","IE0002141913.USD","LU1037948897.HKD","LU0211331839.USD","BK4007","LU2023250843.SGD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","SG9999014567.USD","IE00BJT1NW94.SGD","BK4533","LU1917777945.USD","LU1116320737.USD","LU1941712264.USD","IE00BLSP4452.SGD","LU1974910355.USD","LU0965509101.SGD","SG9999002232.USD","LU1934455863.HKD","MRK","LU0965508806.USD","LU2461242641.AUD","SG9999014542.SGD","LU2089984988.USD","SG9999015358.SGD","LU2112291526.USD","LU0861579265.USD","BK4559","LU2324357040.USD","LU1066053197.SGD","LU1066051225.USD"],"gpt_icon":0},{"id":"2485957914","title":"默沙东(MRK.US)HIF-2α抑制剂在华获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2485957914","media":"智通财经","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485957914?lang=zh_cn&edition=full","pubTime":"2024-11-21 21:12","pubTimestamp":1732194720,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,11月21日,国家药监局网站显示,默沙东(MRK.US)的Belzutifan片(贝组替凡片)获批上市,适应症为von Hippel-Lindau(VHL)病相关肾细胞癌(RCC)、中枢神经系统(CNS)血管母细胞瘤或胰腺神经内分泌肿瘤(pNET)。VHL是一种罕见的遗传性疾病,每3.6万人中就有1人患病。VHL患者不仅有罹患良性血管肿瘤的风险,也有罹患某些癌症的风险,包括肾细胞癌。Belzutifan是一款小分子缺氧诱导因子2α(HIF-2α)抑制剂,可以减少与细胞增殖、血管生成和肿瘤生长相关的HIF-2α靶基因的转录和表达。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1214295.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0203345920.USD","LU0320765489.SGD","LU1934455277.USD","IE00BJJMRZ35.SGD","LU0122379950.USD","LU0234572021.USD","LU1037948541.HKD","BK4559","LU0965508806.USD","LU0265550946.USD","LU0965509010.AUD","LU1093756168.USD","LU1066051811.HKD","SG9999015341.SGD","LU0289739699.SGD","LU1093756325.SGD","BK4550","LU0006306889.USD","LU1066051225.USD","LU2112291526.USD","BK4516","LU2106854487.HKD","LU1116320901.HKD","MRK","IE00BSNM7G36.USD","IE0002141913.USD","BK4534","LU1291159041.SGD","LU1989772840.SGD","IE00B4R5TH58.HKD","LU1585245621.USD","LU2361044949.HKD","BK4585","LU1983299246.USD","LU0266013472.USD","LU0965509101.SGD","LU0208291251.USD","SG9999014567.USD","LU2361044865.SGD","LU1066053197.SGD","SGXZ57979304.SGD","LU1934455863.HKD","SG9999002224.SGD","LU1023059063.AUD","LU1037948897.HKD","LU1934455194.USD","IE000M9KFDE8.USD","SG9999001176.SGD","LU0265550359.USD","IE0009355771.USD"],"gpt_icon":0},{"id":"2485431246","title":"港股异动 | 和誉-B(02256)再涨近4% 匹米替尼III期临床结果公布 默克有较大可能行使全球商业化选择权","url":"https://stock-news.laohu8.com/highlight/detail?id=2485431246","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485431246?lang=zh_cn&edition=full","pubTime":"2024-11-21 14:43","pubTimestamp":1732171390,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,和誉-B午后再涨近4%,截至发稿,涨3.91%,报4.52港元,成交额1098.92万港元。据悉,2023年12月,和誉将pimicotinib大中华区商业化权益及全球权益优先选择权以总额最高达6.055亿美元的首付款、行权款及里程碑付款以及双位数销售分成授予默克。中金认为,pimicotinib有竞争力的TGCT和cGvHD数据有望成为默克行使海外选择权的重要参考,若行权则或在2025年为和誉带来可观的里程碑付款,增厚公司业绩。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1213923.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02256","LU0265550946.USD","MRK","LU1974910355.USD","SG9999001440.SGD","LU0320765489.SGD","IE0002141913.USD","LU0985320562.USD","IE00B1BXHZ80.USD","LU1066051498.USD","LU2461242641.AUD","BK4516","LU0122379950.USD","LU1057294990.SGD","LU0861579265.USD","LU1989772923.USD","LU1941712348.USD","LU0203345920.USD","LU1037948897.HKD","BK4533","SG9999001176.USD","SG9999013999.USD","LU1066051225.USD","LU1430594728.SGD","LU2361045086.USD","LU0965509010.AUD","III","LU0211331839.USD","BK4534","SG9999002232.USD","LU1116320901.HKD","SGXZ57979304.SGD","IE00B2B36J28.USD","LU1983299246.USD","LU2089984988.USD","BK4559","LU1291159041.SGD","SG9999015341.SGD","LU0006306889.USD","BK4585","BK4134","LU0070302665.USD","LU0965508806.USD","SG9999015358.SGD","LU2023250504.SGD","LU1585245621.USD","LU1989771016.USD","LU0208291251.USD","LU1941712264.USD","IE0009355771.USD"],"gpt_icon":0},{"id":"2485810821","title":"牵手默沙东、获中生制药入股!礼新医药成创新药黑马,管线BD交易总额已超280亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2485810821","media":"时代周报","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485810821?lang=zh_cn&edition=full","pubTime":"2024-11-21 07:33","pubTimestamp":1732145585,"startTime":"0","endTime":"0","summary":"本文来源:时代周报 作者:杜苏敏短短一周时间,两笔BD(商务拓展)交易,且交易总额超过200亿元,创新药企业礼新医药一时间成为业内关注的焦点。11月20日,中国生物制药(01177.HK,下称“中生制药”)公告宣布,其与礼新医药签署了股权投资及战略合作协议。据此,中生制药将以1.42亿元的投资,获得礼新医药4.91%的股权,...","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/OAVdmM_-63ZvduFJMxBjAcjEaLNfEpC2fA6L6n6mV-puEAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OAVdmM_-63ZvduFJMxBjAcjEaLNfEpC2fA6L6n6mV-puEAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241121A0146400","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241121A0146400","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["01477","SG9999015341.SGD","LU2361044865.SGD","LU1585245621.USD","LU0234572021.USD","SG9999001176.USD","SG9999014567.USD","LU2324357040.USD","SG9999001440.SGD","LU1941712348.USD","LU0965509010.AUD","LU0006306889.USD","LU0320765489.SGD","IE00B2B36J28.USD","LU0985320562.USD","LU2089984988.USD","LU1037948897.HKD","MRK","09939","BK4588","LU1093756325.SGD","LU1057294990.SGD","LU0265550359.USD","LU2023250843.SGD","IE00BBT3K403.USD","LU0058720904.USD","SG9999002232.USD","BK4007","LU2361045086.USD","IE00BLSP4452.SGD","06978","LU1037948541.HKD","IE00BSNM7G36.USD","LU0203347892.USD","LU1061106388.HKD","LU1291159041.SGD","LU1989771016.USD","LU0106261372.USD","LU1093756168.USD","LU1934455863.HKD","LU1989772923.USD","LU0208291251.USD","BK4534","BK4559","LU1066051498.USD","LU2023250504.SGD","LU2106854487.HKD","SG9999014542.SGD","IE00BLSP4239.USD","LU2361044949.HKD"],"gpt_icon":0},{"id":"2484148304","title":"默沙东上涨1.31%,报97.8美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2484148304","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484148304?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:54","pubTimestamp":1732114494,"startTime":"0","endTime":"0","summary":"11月20日,默沙东(MRK)盘中上涨1.31%,截至22:54,报97.8美元/股,成交7088.46万美元。财务数据显示,截至2024年09月30日,默沙东收入总额485.44亿美元,同比增长6.73%;归母净利润133.74亿美元,同比增长740.6%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/11/20225445506612.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["IE00B2B36J28.USD","LU1989771016.USD","IE00B1BXHZ80.USD","LU0203347892.USD","LU0070302665.USD","LU0208291251.USD","SGXZ57979304.SGD","SG9999013999.USD","IE0002141913.USD","LU0289739699.SGD","LU1057294990.SGD","IE00BJT1NW94.SGD","LU0985320562.USD","BK4533","IE00BN8TJ469.HKD","LU0006306889.USD","IE00BLSP4452.SGD","SG9999001176.USD","IE00B4R5TH58.HKD","LU0861579265.USD","LU1917777945.USD","LU2468319806.SGD","IE00BLSP4239.USD","IE0009355771.USD","SG9999002232.USD","MRK","LU1291159041.SGD","LU0965509101.SGD","LU2112291526.USD","LU1066051498.USD","LU1037948541.HKD","LU1941712264.USD","BK4559","LU2089984988.USD","LU1989772840.SGD","IE00BSNM7G36.USD","LU1941712348.USD","LU0965509283.SGD","SG9999014567.USD","LU0211331839.USD","BK4588","IE00BFTCPJ56.SGD","LU1066051811.HKD","LU1430594728.SGD","BK4007","IE00BJJMRZ35.SGD","LU1093756168.USD","LU2023250843.SGD","LU0106261372.USD","SG9999015358.SGD"],"gpt_icon":0},{"id":"2484166890","title":"媒体-随着本土竞争加剧,J&J和默克在华裁员 - 彭博新闻社","url":"https://stock-news.laohu8.com/highlight/detail?id=2484166890","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484166890?lang=zh_cn&edition=full","pubTime":"2024-11-20 16:28","pubTimestamp":1732091290,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 11月20日 - -- 来源链接: -- 注:路透未核实此报道,不保证其准确性","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","IE00B1BXHZ80.USD","LU1894683348.USD","LU0640476718.USD","SG9999015341.SGD","JNJ","LU1917777945.USD","LU1261432733.SGD","LU0912757837.SGD","LU0320765646.SGD","LU1066051811.HKD","IE00BVYPNW00.USD","MRK","IE00B3PB1722.GBP","LU1057294990.SGD","LU1116320737.USD","IE000M9KFDE8.USD","LU2023250504.SGD","LU2361045086.USD","SG9999001440.SGD","LU0882574055.USD","LU1037948897.HKD","LU2112291526.USD","LU1934455194.USD","BK4592","LU1061106388.HKD","SG9999014567.USD","SG9999015358.SGD","LU0889566641.SGD","LU1037948541.HKD","BK4007","LU1244550494.USD","LU1989771016.USD","LU1430594728.SGD","LU1267930813.SGD","SG9999013999.USD","LU0058720904.USD","LU0006306889.USD","LU1732800096.USD","LU0203345920.USD","LU0795875169.SGD","LU2089984988.USD","BK4516","IE0002141913.USD","LU1023059063.AUD","LU2023250843.SGD","LU0795875086.SGD","LU0965508806.USD","BK4504","BK4533"],"gpt_icon":0},{"id":"2484155652","title":"港股异动 | 和誉-B(02256)现涨超4% 匹米替尼III期临床试验结果公布 默克若选择行权将增厚公司业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2484155652","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484155652?lang=zh_cn&edition=full","pubTime":"2024-11-20 13:49","pubTimestamp":1732081752,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,和誉-B(02256)盘中涨超8%,截至发稿,涨4.15%,报4.27港元,成交额633.5万港元。消息面上,和誉公布,其附属和誉医药自主研发的CSF-1R小分子抑制剂匹米替尼治疗腱鞘巨细胞瘤(TGCT)患者的MANEUVER关键3期研究,取得积极顶线结果以及匹米替尼治疗TGCT的最新1期研究结果。据悉,2023年12月,和誉医药与德国默克公司就Pimicotinib达成独家许可协议。中金认为,pimicotinib有竞争力的TGCT和cGvHD数据有望成为默克行使海外选择权的重要参考,若行权则或在2025年为和誉带来可观的里程碑付款,增厚公司业绩。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1213312.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0211331839.USD","03347","LU0320765489.SGD","02256","BK1576","BK4134","LU1066051225.USD","LU0265550359.USD","IE00B1BXHZ80.USD","BK1583","IE00BLSP4452.SGD","LU1093756325.SGD","SG9999014559.SGD","BK1161","LU1057294990.SGD","LU2361044949.HKD","SG9999001176.SGD","SG9999014567.USD","LU1093756168.USD","LU1061106388.HKD","LU1989772840.SGD","LU2324357040.USD","LU1116320901.HKD","LU0234572021.USD","BK4516","LU0965509283.SGD","SGXZ57979304.SGD","LU1066051811.HKD","III","LU1941712348.USD","LU2089984988.USD","SG9999015358.SGD","BK1141","LU0265550946.USD","LU0266013472.USD","LU0965509101.SGD","LU2112291526.USD","LU1934455277.USD","LU1941712264.USD","MRK","IE0009355771.USD","SG9999001440.SGD","LU0006306889.USD","SG9999002232.USD","BK4550","IE00BLSP4239.USD","IE0002141913.USD","SG9999014542.SGD","BK4007","LU2488822045.USD"],"gpt_icon":0},{"id":"2484663151","title":"牵手默沙东、阿斯利康、中生制药,礼新医药两年卖出280亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2484663151","media":"新康界","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484663151?lang=zh_cn&edition=full","pubTime":"2024-11-20 13:23","pubTimestamp":1732080217,"startTime":"0","endTime":"0","summary":"11月20日早上,中国生物制药公告宣布,其与创新药企业礼新医药签署了股权投资及战略合作协议。先后牵手阿斯利康、默沙东,近三年礼新医药管线BD的交易总额至少已达280亿元。目前与中国生物制药的具体交易尚未可知,而仅算上与默沙东最新达成的总额可达32.88亿美元的交易,礼新医药近两年两款产品就卖出了近39亿美元,折合人民币超280亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120144131abd1322f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120144131abd1322f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BFTCPJ56.SGD","LU2456880835.USD","01177","IE0009355771.USD","LU0320765489.SGD","LU1934455277.USD","LU0070302665.USD","IE00BLSP4239.USD","LU2361044865.SGD","LU0109394709.USD","AZN","LU0208291251.USD","BK4568","LU1989771016.USD","LU2417539215.USD","LU1983299246.USD","LU1061106388.HKD","BK4550","IE000M9KFDE8.USD","LU1066053197.SGD","LU1941712348.USD","LU0861579265.USD","LU0965509101.SGD","SG9999001440.SGD","LU1934455194.USD","MRK","SG9999014559.SGD","LU1974910355.USD","IE00B4R5TH58.HKD","SG9999001176.SGD","IE00BLSP4452.SGD","LU0238689110.USD","LU1057294990.SGD","LU2468319806.SGD","LU0234572021.USD","SG9999013999.USD","SG9999015341.SGD","LU1037948897.HKD","LU1093756325.SGD","LU0320765992.SGD","IE0002141913.USD","SG9999014567.USD","BK4533","IE00BSNM7G36.USD","BK4588","LU2236285917.USD","LU2462157665.USD","LU1989772840.SGD","SG9999014575.USD","LU0266013472.USD","LU2461242641.AUD"],"gpt_icon":0},{"id":"2484110134","title":"专利悬崖危机解除?默沙东(MRK.US)Keytruda皮下注射版本达到3期试验主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2484110134","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484110134?lang=zh_cn&edition=full","pubTime":"2024-11-20 11:50","pubTimestamp":1732074641,"startTime":"0","endTime":"0","summary":"默沙东表示,在一项关键的3期试验中,皮下注射版本的抗PD1药物达到了主要目标,其表现与FDA批准的静脉注射版本相当,是肺癌的一线选择。","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20241120/20241120114504_76998.png?x-oss-process=image/format,jpg/quality,Q_80","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20241120/20241120114504_76998.png?x-oss-process=image/format,jpg/quality,Q_80"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1213291.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU1066051811.HKD","LU1941712348.USD","SG9999001440.SGD","IE00BSNM7G36.USD","LU0203345920.USD","LU0265550359.USD","SG9999001176.SGD","LU1116320737.USD","LU2112291526.USD","BK4534","SG9999015341.SGD","LU1934455863.HKD","SG9999002224.SGD","LU0965509010.AUD","LU1023059063.AUD","LU1989772840.SGD","LU0861579265.USD","LU2106854487.HKD","LU1093756325.SGD","SG9999002232.USD","LU1585245621.USD","LU2461242641.AUD","LU0106261372.USD","LU0058720904.USD","IE00BJT1NW94.SGD","SG9999014567.USD","LU1983299246.USD","LU1989771016.USD","IE0002141913.USD","MRK","LU1934455194.USD","BK4516","BK4588","LU1989772923.USD","BK4559","LU1291159041.SGD","LU2023250504.SGD","LU1116320901.HKD","LU0289739699.SGD","SG9999014559.SGD","LU0203347892.USD","LU1057294990.SGD","LU1974910355.USD","LU1066051498.USD","SG9999014542.SGD","LU1934455277.USD","IE00B4R5TH58.HKD","LU0238689110.USD","LU1061106388.HKD","LU2023250843.SGD"],"gpt_icon":0},{"id":"2484139314","title":"默沙东中国市场挑战加剧:业绩缩水,裁员计划开启","url":"https://stock-news.laohu8.com/highlight/detail?id=2484139314","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484139314?lang=zh_cn&edition=full","pubTime":"2024-11-20 11:07","pubTimestamp":1732072058,"startTime":"0","endTime":"0","summary":"继强生公司启动新一轮的裁员调整之后,另一家知名的跨国制药企业默沙东也在中国市场宣布了裁员计划。然而,截至发稿前,默沙东中国方面尚未给出任何回复。默沙东的西格列汀是中国首款上市的DPP-4抑制剂,占据DPP-4抑制剂市场的榜首。上述相关人士指出,默沙东近期的裁员是由于糖尿病业务部门受到集采政策的较大冲击。从默沙东目前的业绩表现来看,PD-1业务板块为其贡献显著。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120111557a2475e98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120111557a2475e98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2023250843.SGD","LU1934455277.USD","LU1989771016.USD","LU1066051225.USD","LU0122379950.USD","LU2468319806.SGD","LU1093756168.USD","LU2324357040.USD","LU0106261372.USD","LU1291159041.SGD","SG9999001440.SGD","LU1934455863.HKD","LU1061106388.HKD","IE0009355771.USD","LU2023250504.SGD","IE00BLSP4239.USD","LU0070302665.USD","LU1037948897.HKD","LU2361044865.SGD","SG9999013999.USD","LU0211331839.USD","BK4533","MRK","YINN","LU1989772840.SGD","LU0266013472.USD","BK4585","LU1989772923.USD","LU2361044949.HKD","LU1093756325.SGD","LU2361045086.USD","LU0203347892.USD","SG9999002224.SGD","LU1057294990.SGD","IE00B2B36J28.USD","LU1037948541.HKD","LU1941712264.USD","SG9999002232.USD","LU1585245621.USD","LU1983299246.USD","SG9999001176.USD","LU1941712348.USD","LU1934455194.USD","LU0203345920.USD","IE00BJT1NW94.SGD","BK4534","IE00B1BXHZ80.USD","LU0861579265.USD","IE000M9KFDE8.USD","LU0289739699.SGD"],"gpt_icon":0},{"id":"2484947569","title":"BUZZ-默克公司在发现注射用 Keytruda 与已获批准的静脉注射型相同后股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2484947569","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484947569?lang=zh_cn&edition=full","pubTime":"2024-11-19 22:08","pubTimestamp":1732025289,"startTime":"0","endTime":"0","summary":"11月19日 - ** 默克公司MRK.N股价盘前上涨近1%至97.39美元 ** MRK最畅销药物Keytruda的注射版 ,该公司表示,在后期研究中,该药物的效果并不逊色于已获批准的静脉注射版。** MRK表示,该研究主要针对一种肺癌患者 ** 注射剂将 Keytruda 与透明质酸酶 alfa 结合在一起,透明质酸酶 alfa 是一种能帮助人体更好地吸收和扩散注射药物的酶。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241119:nL4T3MQ18L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","LU0234572021.USD","LU2023250504.SGD","LU1430594728.SGD","LU2112291526.USD","SG9999002224.SGD","LU0266013472.USD","LU2468319806.SGD","BK4588","LU0203345920.USD","LU0265550946.USD","LU0965509101.SGD","LU1983299246.USD","LU2361044949.HKD","SGXZ57979304.SGD","LU0006306889.USD","LU0289739699.SGD","LU0965508806.USD","LU1093756325.SGD","SG9999014542.SGD","LU0965509283.SGD","BK4585","LU1989771016.USD","IE00BJJMRZ35.SGD","LU0985320562.USD","LU1066051811.HKD","LU1934455194.USD","IE00BSNM7G36.USD","MRK","SG9999014575.USD","LU0861579265.USD","LU1037948541.HKD","LU1023059063.AUD","LU1917777945.USD","IE00B1BXHZ80.USD","LU1941712264.USD","LU1934455863.HKD","SG9999001176.SGD","SG9999014567.USD","LU0070302665.USD","SG9999001176.USD","IE000M9KFDE8.USD","IE00BFTCPJ56.SGD","LU1116320737.USD","IE00B4R5TH58.HKD","LU1989772923.USD","SG9999002232.USD","LU1061106388.HKD","SG9999015358.SGD","LU1066051225.USD"],"gpt_icon":0},{"id":"2484434219","title":"又一家跨国药企在华人员优化 这次是默沙东中国糖尿病业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2484434219","media":"第一财经","labels":["Executive Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484434219?lang=zh_cn&edition=full","pubTime":"2024-11-19 20:23","pubTimestamp":1732019027,"startTime":"0","endTime":"0","summary":"继强生之后,又一家跨国药企传出裁员消息。有市场消息称,默沙东中国糖尿病业务因药品集采在裁员中。第一财经记者向默沙东中国官方求证,截至发稿时尚未获得回复。不过,第一财经记者从默沙东内部人士证实了该消息的真实性,但裁员幅度暂不详。默沙东旗下有三款糖尿病药物,分别是西格列汀、西格列汀二甲双胍、艾托格列净,前两款药物是公司糖尿病业务的主要销售来源。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202411193244442093.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411193244442093.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Executive Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0208291251.USD","LU1066051811.HKD","LU2361044949.HKD","BK4585","LU1066053197.SGD","LU0203345920.USD","LU1037948541.HKD","LU1066051498.USD","SG9999014575.USD","IE00B1BXHZ80.USD","SG9999001440.SGD","LU1057294990.SGD","BK4588","LU1116320901.HKD","IE0002141913.USD","LU0106261372.USD","LU1941712264.USD","IE00BLSP4452.SGD","LU0265550359.USD","SG9999014542.SGD","BK4533","LU1093756168.USD","SG9999014567.USD","LU0985320562.USD","LU1066051225.USD","IE00BJJMRZ35.SGD","LU2023250843.SGD","LU0211331839.USD","LU0289739699.SGD","SG9999001176.USD","LU1917777945.USD","LU0965509010.AUD","LU1061106388.HKD","LU2106854487.HKD","BK4550","IE00B2B36J28.USD","LU0006306889.USD","LU1037948897.HKD","LU2361045086.USD","LU1989772923.USD","MRK","LU1116320737.USD","BK4516","LU2112291526.USD","SGXZ57979304.SGD","LU1974910355.USD","IE00B4R5TH58.HKD","LU1093756325.SGD","LU2023250504.SGD","SG9999013999.USD"],"gpt_icon":0},{"id":"2484948140","title":"国产分子在海外成为王炸","url":"https://stock-news.laohu8.com/highlight/detail?id=2484948140","media":"瞪羚社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484948140?lang=zh_cn&edition=full","pubTime":"2024-11-19 20:04","pubTimestamp":1732017840,"startTime":"0","endTime":"0","summary":"上方“瞪羚社”即刻关注并加入社群 聚焦高成长公司,100000+投资菁英共同关注 近日,BionTech在完成普米斯双抗的BD交易后选择了更进一步:彻底收购了普米斯这家中国的多抗....","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/OHblOLnko3fTBs5rlhJDn9lNxReWWys99rJ7NItP5ybeUAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OHblOLnko3fTBs5rlhJDn9lNxReWWys99rJ7NItP5ybeUAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241119A08Z1Q00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241119A08Z1Q00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["LU0265550359.USD","LU2361044949.HKD","LU1989771016.USD","IE00B1BXHZ80.USD","IE00BBT3K403.USD","LU0070302665.USD","BK4585","SG9999014559.SGD","SGXZ57979304.SGD","SG9999013999.USD","LU0122379950.USD","IE0002141913.USD","TRAE","BK4107","LU0289739699.SGD","LU0203345920.USD","LU0234572021.USD","IE00BJT1NW94.SGD","LU0265550946.USD","LU0985320562.USD","LU1066053197.SGD","BK4533","IE00BN8TJ469.HKD","LU1023059063.AUD","LU2324357040.USD","LU0238689110.USD","LU1934455863.HKD","LU0861579265.USD","LU1917777945.USD","IE00BLSP4239.USD","BK4550","MRK","LU1934455277.USD","LU1941712264.USD","LU1037948541.HKD","SG9999001176.SGD","BK4534","LU1430594728.SGD","IE00BFTCPJ56.SGD","LU1066051811.HKD","LU1983299246.USD","BK4007","LU0266013472.USD","L","LU1093756168.USD","LU2361044865.SGD","LU1989772923.USD","SG9999002224.SGD","LU1061106388.HKD","BK4516"],"gpt_icon":0},{"id":"2484917915","title":"默克公司称Keytruda注射液在试验中与已获批的静脉注射版效果相当","url":"https://stock-news.laohu8.com/highlight/detail?id=2484917915","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484917915?lang=zh_cn&edition=full","pubTime":"2024-11-19 19:46","pubTimestamp":1732016797,"startTime":"0","endTime":"0","summary":" 路透11月19日 - 默克公司 周二表示,一项研究表明,其抗癌药物Keytruda的注射剂并不比目前获批的静脉注射剂型差,这可能使其更容易获得和使用。默克公司研究部门肿瘤学、全球临床开发负责人玛乔丽-格林说,默克公司计划尽快与全球监管机构讨论这一结果。默克公司说,尽管给药时间短,但注射型药物在患者体内的暴露量以及在下一次给药前的浓度方面也并不逊色。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1941712348.USD","LU2468319806.SGD","LU0203345920.USD","LU1917777945.USD","LU0070302665.USD","LU1116320737.USD","LU0234572021.USD","BK4534","SG9999015341.SGD","LU1066053197.SGD","LU2089984988.USD","LU0965509010.AUD","LU0861579265.USD","LU1066051225.USD","LU1093756325.SGD","LU1430594728.SGD","LU1585245621.USD","SG9999002232.USD","LU0965509101.SGD","SG9999015358.SGD","LU1037948541.HKD","LU0106261372.USD","IE00BBT3K403.USD","IE00BLSP4452.SGD","IE00BJT1NW94.SGD","LU0320765489.SGD","LU0211331839.USD","SG9999001176.USD","LU1989771016.USD","SG9999014567.USD","LU0266013472.USD","LU0985320562.USD","MRK","BK4533","BK4516","IE00B1BXHZ80.USD","BK4588","LU2023250504.SGD","LU2361045086.USD","LU0289739699.SGD","SG9999014559.SGD","LU1057294990.SGD","LU2361044949.HKD","IE00BJJMRZ35.SGD","LU1934455277.USD","BK4550","BK4007","IE00B2B36J28.USD","LU1061106388.HKD","LU2023250843.SGD"],"gpt_icon":0},{"id":"2484750961","title":"一周内官宣4笔BD交易!双抗新药赛道火爆,跨国药企砸百亿在华“扫货”","url":"https://stock-news.laohu8.com/highlight/detail?id=2484750961","media":"时代财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484750961?lang=zh_cn&edition=full","pubTime":"2024-11-19 14:17","pubTimestamp":1731997033,"startTime":"0","endTime":"0","summary":"本文来源:时代财经 作者:李傲华双抗赛道日渐升温。11月18日,橙帆医药宣布与Avenzo Therapeutics达成一项全球战略合作协议,橙帆医药将授予Avenzo在全球范围内(不包括大中华区)开发、生产和商业化Nectin4/TROP2双特异性抗体偶联药物(ADC),同时保留在大中华区的相关权益。根据约定,橙帆医药可以获得5000万美元的首付...","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/OGXNPipjng5N0EEVqCMMar7oEn1NEUUoSMX0OgZcn7fE0AA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OGXNPipjng5N0EEVqCMMar7oEn1NEUUoSMX0OgZcn7fE0AA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241119A052YN00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241119A052YN00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["LU1057294990.SGD","LU0985320562.USD","SG9999013999.USD","LU0417516571.SGD","LU2461242641.AUD","BK4588","PML","LU1066053197.SGD","09939","LU0289739699.SGD","LU0106261372.USD","GSK","LU1934455863.HKD","BK4080","GSK.UK","LU1061106388.HKD","LU0203347892.USD","LU1116320901.HKD","MRK","LU0053671581.USD","BK4007","SG9999014542.SGD","09926","LU0266013472.USD","SGXZ57979304.SGD","LU1116320737.USD","SG9999015341.SGD","BK4211","LU2112291526.USD","LU2023250504.SGD","IE0002141913.USD","BMS","L","LU0965509010.AUD","IE00BJJMRZ35.SGD","ADC","SG9999001176.SGD","IE00BLSP4239.USD","BK4231","LU1023059063.AUD","BK4534","HR","IE00B1BXHZ80.USD","BK4107","ITT","02162","SG9999001176.USD","LU1934455194.USD","SG9999014559.SGD","PFS"],"gpt_icon":0},{"id":"2484626006","title":"默沙东:质疑Summit,成为Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2484626006","media":"新康界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484626006?lang=zh_cn&edition=full","pubTime":"2024-11-18 19:10","pubTimestamp":1731928222,"startTime":"0","endTime":"0","summary":"LM-299刚刚进入1期临床,默沙东支付的首付款要高于Summit,可能一定程度上反应了:默沙东也有点着急了。正所谓,质疑Summit,成为Summit。结果公布之后,康方生物合作伙伴Summit股价连续多日大涨,市值一度高达245亿美元。9月份以来,Summit股价暴涨,引发了全球市场对于PD-1/VEGF双抗的关注,甚至可以说是热潮:全球药企,都开始围猎PD-1/VEGF双抗。BioNtech也证实BNT327的 3期试验计划重点针对此类患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118195550abcc68c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118195550abcc68c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1116320901.HKD","LU1291159041.SGD","LU0265550946.USD","IE00BLSP4452.SGD","BK4585","IE00B1BXHZ80.USD","LU1941712348.USD","SG9999015341.SGD","BK4007","LU0234572021.USD","MRK","SG9999014559.SGD","SGXZ57979304.SGD","IE00BJT1NW94.SGD","LU1585245621.USD","LU1941712264.USD","LU2023250843.SGD","LU0861579265.USD","LU1116320737.USD","LU0965509010.AUD","SG9999013999.USD","LU1066053197.SGD","LU0211331839.USD","LU2089984988.USD","LU1989772840.SGD","LU1066051811.HKD","IE00BSNM7G36.USD","LU1066051225.USD","SG9999014542.SGD","LU1430594728.SGD","LU0208291251.USD","LU1093756168.USD","LU1934455863.HKD","LU1989772923.USD","LU1066051498.USD","BK4588","LU2361044865.SGD","LU1023059063.AUD","IE00BJJMRZ35.SGD","SG9999001176.USD","SG9999002232.USD","LU0238689110.USD","LU2324357040.USD","LU1037948541.HKD","BK4533","IE00BN8TJ469.HKD","IE00BFTCPJ56.SGD","LU1061106388.HKD","LU2361045086.USD","BK4534"],"gpt_icon":0},{"id":"2484838426","title":"“新冠富豪”再加码,默沙东态度大转变,下一个大药机会来临","url":"https://stock-news.laohu8.com/highlight/detail?id=2484838426","media":"CPHI制药在线","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484838426?lang=zh_cn&edition=full","pubTime":"2024-11-17 17:02","pubTimestamp":1731834139,"startTime":"0","endTime":"0","summary":"2020年,成立12年的BioNTech凭借mRNA新冠疫苗一战成名,有“新冠富豪”之称。在本次交易完成后,BioNTech将获得普米斯候选药物管线及其双特异性抗体药物开发平台的全部权利。至此,HARMONi-2研究成为全球首个对比K药取得显著阳性结果的随机对照III期临床研究,在肿瘤免疫治疗领域引起了巨大反响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117170732a23f99ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117170732a23f99ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999015341.SGD","LU1934455194.USD","LU2361044865.SGD","IE00BJT1NW94.SGD","LU0965509101.SGD","LU1585245621.USD","LU1430594728.SGD","LU0234572021.USD","LU2112291526.USD","SG9999014559.SGD","LU2324357040.USD","IE0009355771.USD","IE00BN8TJ469.HKD","SG9999014575.USD","IE00B1BXHZ80.USD","LU0965509010.AUD","LU0006306889.USD","LU0320765489.SGD","IE00B2B36J28.USD","LU1116320901.HKD","LU2089984988.USD","MRK","LU1093756325.SGD","SG9999015358.SGD","BK4516","LU0265550359.USD","IE00BBT3K403.USD","LU0058720904.USD","LU0965509283.SGD","SG9999002232.USD","BK4533","LU0265550946.USD","SG9999013999.USD","IE00BLSP4452.SGD","LU1037948541.HKD","LU0203347892.USD","LU1066053197.SGD","LU1989771016.USD","LU1291159041.SGD","LU1989772923.USD","BK4585","BK4550","LU1934455863.HKD","LU1983299246.USD","LU0208291251.USD","BK4559","LU2106854487.HKD","SG9999014542.SGD","LU0238689110.USD","LU2461242641.AUD"],"gpt_icon":0},{"id":"2483565108","title":"近33亿美元!默沙东“牵手”礼新医药,PD-(L)1/VEGF领域交易频发","url":"https://stock-news.laohu8.com/highlight/detail?id=2483565108","media":"21世纪经济报道","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483565108?lang=zh_cn&edition=full","pubTime":"2024-11-16 12:32","pubTimestamp":1731731534,"startTime":"0","endTime":"0","summary":"21世纪经济报道记者韩利明上海报道连日来,PD-(L)1/VEGF双特异性抗体领域迎来多起重磅交易。14日晚间,默沙东宣布已协议获得礼新医药新型在研PD-1/VEGF双特异性抗体LM-299的全球开发、生产和商业化独家许可。根据协议条款,礼新医药将获得5.88亿美元的首付款及最高27亿美元的里程碑付款。该交易预计将于2024年第四季度完成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202411163241601423.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411163241601423.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0985320562.USD","SG9999013999.USD","IE00BN8TJ469.HKD","LU1066051225.USD","LU2461242641.AUD","LU1983299246.USD","IE00BBT3K403.USD","LU2106854487.HKD","PD","09939","LU0058720904.USD","LU0106261372.USD","IE00B2B36J28.USD","LU1093756168.USD","SG9999014575.USD","LU1169589451.USD","LU0211331839.USD","SG9999015358.SGD","BK1515","LU1061106388.HKD","LU2324357040.USD","LU0203347892.USD","BK4023","MRK","BK4007","LU1917777945.USD","LU1941712264.USD","IE00BFTCPJ56.SGD","LU0861579265.USD","LU0208291251.USD","LU1169590202.USD","LU1116320737.USD","SG9999015341.SGD","LU2023250843.SGD","BK4559","IE0009355771.USD","IE0002141913.USD","LU2089984988.USD","L","BK4585","LU0203345920.USD","LU0965509010.AUD","SG9999001176.SGD","LU1941712348.USD","IE000M9KFDE8.USD","LU0965508806.USD","LU0965509101.SGD","LU1037948541.HKD","LU2361045086.USD","LU0234572021.USD"],"gpt_icon":0},{"id":"2483738558","title":"多种模式并驾齐驱 创新药出海捷报频传","url":"https://stock-news.laohu8.com/highlight/detail?id=2483738558","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483738558?lang=zh_cn&edition=full","pubTime":"2024-11-16 08:29","pubTimestamp":1731716986,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU1989772840.SGD","LU1066053197.SGD","LU2023250504.SGD","LU0265550946.USD","BK0196","LU0266013472.USD","SG9999002232.USD","LU0070302665.USD","LU0203345920.USD","BK4550","BK0060","LU0289739699.SGD","LU2361044865.SGD","BK1574","159992","LU1169589451.USD","IE00BJT1NW94.SGD","LU1057294990.SGD","161726","PD","SG9999002224.SGD","LU1983299246.USD","SG9999001440.SGD","02162","LU1917777945.USD","LU2089984988.USD","LU1169590202.USD","IE00BN8TJ469.HKD","BK0188","LU1291159041.SGD","06978","BK1161","399441","LU1066051225.USD","LU1093756325.SGD","SG9999014575.USD","LU0208291251.USD","LU2106854487.HKD","SG9999014559.SGD","LU1064130708.USD","BK4534","LU1061106388.HKD","09939","159938","BK1583","LU2112291526.USD","MRK","600276","LU0985320562.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.merck.com","stockEarnings":[{"period":"1week","weight":-0.0108},{"period":"1month","weight":-0.0837},{"period":"3month","weight":-0.164},{"period":"6month","weight":-0.2475},{"period":"1year","weight":-0.0467},{"period":"ytd","weight":-0.1062}],"compareEarnings":[{"period":"1week","weight":-0.0112},{"period":"1month","weight":0.0118},{"period":"3month","weight":0.0616},{"period":"6month","weight":0.1153},{"period":"1year","weight":0.3028},{"period":"ytd","weight":0.2423}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"默克制药公司于1970年在新泽西州注册成立。该公司是一家全球医疗保健公司,通过其处方药提供创新的健康解决方案,包括生物疗法、疫苗和动物保健产品。该公司的营运主要以产品为基础进行管理,包括两个经营分部:制药及动物保健国际。","yearOnYearQuotes":[{"month":1,"riseRate":0.568182,"avgChangeRate":0.009892},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.000396},{"month":3,"riseRate":0.636364,"avgChangeRate":-0.002321},{"month":4,"riseRate":0.622222,"avgChangeRate":0.018595},{"month":5,"riseRate":0.644444,"avgChangeRate":0.018719},{"month":6,"riseRate":0.511111,"avgChangeRate":0.01265},{"month":7,"riseRate":0.488889,"avgChangeRate":0.003443},{"month":8,"riseRate":0.488889,"avgChangeRate":0.001677},{"month":9,"riseRate":0.533333,"avgChangeRate":-0.006327},{"month":10,"riseRate":0.533333,"avgChangeRate":0.018591},{"month":11,"riseRate":0.711111,"avgChangeRate":0.02766},{"month":12,"riseRate":0.613636,"avgChangeRate":0.014794}],"exchange":"NYSE","name":"默沙东","nameEN":"Merck"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"默沙东(MRK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供默沙东(MRK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"默沙东,MRK,默沙东股票,默沙东股票老虎,默沙东股票老虎国际,默沙东行情,默沙东股票行情,默沙东股价,默沙东股市,默沙东股票价格,默沙东股票交易,默沙东股票购买,默沙东股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"默沙东(MRK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供默沙东(MRK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}